Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model.
about
Zn2+-SCMC versus HA for preventing intraperitoneal adhesions: a rat model studyRandomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.Efficacy and safety of a combination of hyaluronic acid, chondroitin sulfate, and poloxamer 407 as a submucosal injection solution for endoscopic resection: pilot study on a swine modelA review of pharmacotherapy for treating gastroesophageal reflux disease (GERD).
P2860
Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Barrier effect of Esoxx
@nl
Barrier effect of Esoxx(®) on ...... study on ex-vivo swine model.
@en
type
label
Barrier effect of Esoxx
@nl
Barrier effect of Esoxx(®) on ...... study on ex-vivo swine model.
@en
prefLabel
Barrier effect of Esoxx
@nl
Barrier effect of Esoxx(®) on ...... study on ex-vivo swine model.
@en
P2093
P2860
P356
P1476
Barrier effect of Esoxx(®) on ...... study on ex-vivo swine model.
@en
P2093
Antonella Ferrieri
Fabio Baldi
Fabrizio Scorrano
Gilberto Poggioli
Massimo P Di Simone
Valentina Vasina
P2860
P304
P356
10.2147/CEG.S31404
P407
P577
2012-06-11T00:00:00Z